PL BioScience Announces Exclusive Distributorship Agreement with SPI
PL BioScience announces Distributorship Agreement with SPI
PL BioScience announces Exclusive Distributorship Agreement with Summit Pharmaceuticals International (SPI)
PL BioScience GmbH is proud to announce an exclusive distribution agreement for the Japanese market with Summit Pharmaceuticals International Corporation (SPI) to support local availability of Gamma-Irradiated ELAREM™ Ultimate-FD PLUS Human Platelet Lysate and the broader ELAREM™ platform for clinical and research applications.
Read our Press Release here.
